awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
BLOOD-2011-12-400051
BLOOD-2011-12-400051
http://dx.doi.org/10.1182/BLOOD-2011-12-400051
Phase 2 study of the JAK kinase inhibitor ruxolitinib in patients with refractory leukemias, including postmyeloproliferative neoplasm acute myeloid leukemia.
P356
Q42720284-55A43A6B-C8A8-45CF-9D5A-BC27A68720E6
P356
BLOOD-2011-12-400051
http://dx.doi.org/10.1182/BLOOD-2011-12-400051